Citadel Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Citadel Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,902	Closed	-$686K	–	10301
2018 Q4	$686K	Buy	4,902 +2,240	+84%	+$340K	﹤0.01%	5916
2018 Q3	$455K	Sell	2,662 -18,721	-88%	-$3.15M	﹤0.01%	6848
2018 Q2	$3.71M	Buy	21,383 +14,511	+211%	+$2.18M	﹤0.01%	3180
2018 Q1	$793K	Buy	+6,872	New	+$731K	﹤0.01%	5156
2017 Q4	–	Sell	-35,477	Closed	-$2.96M	–	8716
2017 Q3	$3.27M	Buy	35,477 +9,226	+35%	+$717K	﹤0.01%	2798
2017 Q2	$2.1M	Buy	26,251 +994	+4%	+$55.1K	﹤0.01%	3109
2017 Q1	$1.06M	Buy	+25,257	New	+$1.04M	﹤0.01%	3916
2016 Q1	–	Sell	-25,501	Closed	-$726K	–	8626
2015 Q4	$726K	Buy	+25,501	New	+$684K	﹤0.01%	3986

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Citadel Advisors's LOXO Position: Q1 2019 in Review

Citadel Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,902 shares — an estimated $686K sold.

Citadel Advisors first reported a position in LOXO in Q4 2015 and held it in 8 quarters. The position peaked at $3.71M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Citadel Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Citadel Advisors sold 4,902 Loxo Oncology, Inc shares in Q1 2019, an estimated $686K.
Citadel Advisors first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 8 quarters.
Citadel Advisors's Loxo Oncology, Inc position peaked at $3.71M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.